2014
DOI: 10.1253/circj.cj-14-0077
|View full text |Cite
|
Sign up to set email alerts
|

Status 2 Patients Had Poor Prognosis Without Mechanical Circulatory Support

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
12
0

Year Published

2015
2015
2017
2017

Publication Types

Select...
10

Relationship

6
4

Authors

Journals

citations
Cited by 16 publications
(14 citation statements)
references
References 30 publications
2
12
0
Order By: Relevance
“…Hence, clinical outcomes of patients with chronic HF are now significantly better, but patients with severe chronic HF who do not respond well to standard drug therapies still have poor outcomes. 1 In addition, although patients with end-stage severe HF benefit from heart transplantation or left ventricular assist system (LVAS) implantation, 2 these procedures are indicated for only a limited number of such patients worldwide where the number of heart 992 SAWA Y et al…”
mentioning
confidence: 99%
“…Hence, clinical outcomes of patients with chronic HF are now significantly better, but patients with severe chronic HF who do not respond well to standard drug therapies still have poor outcomes. 1 In addition, although patients with end-stage severe HF benefit from heart transplantation or left ventricular assist system (LVAS) implantation, 2 these procedures are indicated for only a limited number of such patients worldwide where the number of heart 992 SAWA Y et al…”
mentioning
confidence: 99%
“…All patients accomplished CPXT without any complication (maximal load, 75±35 W). The expiratory change ratio was 1.3±0.2 (range 1.1-1.6), and the Borg scale was 18±2 points (range [17][18][19][20].…”
Section: Patients' Backgroundsmentioning
confidence: 98%
“…7) It is no wonder that patients dependent on inotrope infusion soon receive VAD therapy, but more surprisingly survival rates of those who are listed but ambulatory (4-year survival rate, 68%) are similar to the patients once dependent inotrope (4-year survival rate, 65%). This strongly suggests the powerful ability to save life by VAD therapy.…”
Section: Inotrope Infusionmentioning
confidence: 99%